Trials / Completed
CompletedNCT06961643
Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function
Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Mild and Moderate Hepatic Impairment and Normal Hepatic Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to compare the pharmacokinetics and safety of HRS-7535 in subjects with mild to moderate hepatic impairment and normal hepatic function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535 Tables | Oral HRS-7535 tables. |
Timeline
- Start date
- 2025-06-05
- Primary completion
- 2026-01-22
- Completion
- 2026-01-22
- First posted
- 2025-05-08
- Last updated
- 2026-03-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06961643. Inclusion in this directory is not an endorsement.